|
1
|
Valenti MT, Dalle Carbonare L and Mottes
M: Osteogenic differentiation in healthy and pathological
conditions. Int J Mol Sci. 18:E412016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Idolazzi L, Fassio A, Tripi G, Braga V,
Viapiana O, Adami G, Rossini M and Gatti D: Circulating Dickkopf-1
and sclerostin in patients with Paget's disease of bone. Clin
Rheumatol. 36:925–928. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mäkitie RE, Haanpää M, Valta H, Pekkinen
M, Laine CM, Lehesjoki AE, Schalin-Jäntti C and Mäkitie O: Skeletal
characteristics of WNT1 osteoporosis in children and young adults.
J Bone Miner Res. 31:1734–1742. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Papaioannou G, Mirzamohammadi F and
Kobayashi T: MicroRNAs involved in bone formation. Cell Mol Life
Sci. 71:4747–4761. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yuan Y, Zhang L, Tong X, Zhang M, Zhao Y,
Guo J, Lei L, Chen X, Tickner J, Xu J and Zou J: Mechanical stress
regulates bone metabolism through MicroRNAs. J Cell Physiol.
232:1239–1245. 2017. View Article : Google Scholar
|
|
6
|
Ji X, Chen X and Yu X: MicroRNAs in
osteoclastogenesis and function: Potential therapeutic targets for
osteoporosis. Int J Mol Sci. 17:3492016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gennari L, Bianciardi S and Merlotti D:
MicroRNAs in bone diseases. Osteoporos Int. 28:1191–1213. 2017.
View Article : Google Scholar
|
|
8
|
Wu C, Tian B, Qu X, Liu F, Tang T, Qin A,
Zhu Z and Dai K: MicroRNAs play a role in chondrogenesis and
osteoarthritis (Review). Int J Mol Med. 34:13–23. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huang C, Geng J and Jiang S: MicroRNAs in
regulation of osteogenic differentiation of mesenchymal stem cells.
Cell Tissue Res. 368:229–238. 2017. View Article : Google Scholar
|
|
10
|
Kapinas K, Kessler C, Ricks T, Gronowicz G
and Delany AM: miR-29 modulates Wnt signaling in human osteoblasts
through a positive feedback loop. J Biol Chem. 285:25221–25231.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gong Y, Xu F, Zhang L, Qian Y, Chen J,
Huang H and Yu Y: MicroRNA expression signature for Satb2-induced
osteogenic differentiation in bone marrow stromal cells. Mol Cell
Biochem. 387:227–239. 2014. View Article : Google Scholar
|
|
12
|
Huang J, Zhao L, Xing L and Chen D:
MicroRNA-204 regulates Runx2 protein expression and mesenchymal
progenitor cell differentiation. Stem Cells. 28:357–364. 2010.
|
|
13
|
Onyekwelu I, Goldring MB and Hidaka C:
Chondrogenesis, joint formation, and articular cartilage
regeneration. J Cell Biochem. 107:383–392. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tian Y, Guo R, Shi B, Chen L, Yang L and
Fu Q: MicroRNA-30a promotes chondrogenic differentiation of
mesenchymal stem cells through inhibiting Delta-like 4 expression.
Life Sci. 148:220–228. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Miyaki S, Nakasa T, Otsuki S, Grogan SP,
Higashiyama R, Inoue A, Kato Y, Sato T, Lotz MK and Asahara H:
MicroRNA-140 is expressed in differentiated human articular
chondrocytes and modulates interleukin-1 responses. Arthritis
Rheum. 60:2723–2730. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang Z, Hou C, Meng F, Zhao X, Zhang Z,
Huang G, Chen W, Fu M and Liao W: MiR-455-3p regulates early
chondrogenic differentiation via inhibiting Runx2. FEBS Lett.
589:3671–3678. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li H, Li T, Wang S, Wei J, Fan J, Li J,
Han Q, Liao L, Shao C and Zhao RC: miR-17-5p and miR-106a are
involved in the balance between osteogenic and adipogenic
differentiation of adipose-derived mesenchymal stem cells. Stem
Cell Res. 10:313–324. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang J, Guan X, Guo F, Zhou J, Chang A,
Sun B, Cai Y, Ma Z, Dai C, Li X and Wang B: miR-30e reciprocally
regulates the differentiation of adipocytes and osteoblasts by
directly targeting low-density lipoprotein receptor-related protein
6. Cell Death Dis. 10:e8452013. View Article : Google Scholar
|
|
19
|
Zhang JF, Fu WM, He ML, Wang H, Wang WM,
Yu SC, Bian XW, Zhou J, Lin MC, Lu G, et al: MiR-637 maintains the
balance between adipocytes and osteoblasts by directly targeting
Osterix. Mol Biol Cell. 22:3955–3961. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mei Y, Bian C, Li J, Du Z, Zhou H, Yang Z
and Zhao RC: miR-21 modulates the ERK-MAPK signaling pathway by
regulating SPRY2 expression during human mesenchymal stem cell
differentiation. J Cell Biochem. 114:1374–1384. 2013. View Article : Google Scholar
|
|
21
|
Trohatou O, Zagoura D, Bitsika V, Pappa
KI, Antsaklis A, Anagnou NP and Roubelakis MG: Sox2 suppression by
miR-21 governs human mesenchymal stem cell properties. Stem Cells
Transl Med. 3:54–68. 2014. View Article : Google Scholar :
|
|
22
|
Yang N, Wang G, Hu C, Shi Y, Liao L, Shi
S, Cai Y, Cheng S, Wang X, Liu Y, et al: Tumor necrosis factor
alpha suppresses the mesenchymal stem cell osteogenesis promoter
miR-21 in estrogen deficiency-induced osteoporosis. J Bone Miner
Res. 28:559–573. 2013. View Article : Google Scholar
|
|
23
|
Huang S, Wang S, Bian C, Yang Z, Zhou H,
Zeng Y, Li H, Han Q and Zhao RC: Upregulation of miR-22 promotes
osteogenic differentiation and inhibits adipogenic differentiation
of human adipose tissue-derived mesenchymal stem cells by
repressing HDAC6 protein expression. Stem Cells Dev. 21:2531–2540.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Westendorf JJ: Transcriptional
co-repressors of Runx2. J Cell Biochem. 98:54–64. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hu R, Liu W, Li H, Yang L, Chen C, Xia ZY,
Guo LJ, Xie H, Zhou HD, Wu XP and Luo XH: A Runx2/miR-3960/miR-2861
regulatory feedback loop during mouse osteoblast differentiation. J
Biol Chem. 286:12328–12339. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang JF, Fu WM, He ML, Xie WD, Lv Q, Wan
G, Li G, Wang H, Lu G, Hu X, et al: MiRNA-20a promotes osteogenic
differentiation of human mesenchymal stem cells by co-regulating
BMP signaling. RNA Biol. 8:829–838. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gámez B, Rodríguez-Carballo E, Bartrons R,
Rosa JL and Ventura F: MicroRNA-322 (miR-322) and its target
protein Tob2 modulate Osterix (Osx) mRNA stability. J Biol Chem.
288:14264–14275. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bhushan R, Grünhagen J, Becker J, Robinson
PN, Ott CE and Knaus P: miR-181a promotes osteoblastic
differentiation through repression of TGF-β signaling molecules.
Int J Biochem Cell Biol. 45:696–705. 2013. View Article : Google Scholar
|
|
29
|
Zheng L, Tu Q, Meng S, Zhang L, Yu L, Song
J, Hu Y, Sui L, Zhang J, Dard M, et al: Runx2/DICER/miRNA pathway
in regulating osteogenesis. J Cell Physiol. 232:182–191. 2017.
View Article : Google Scholar
|
|
30
|
Li Y, Fan L, Liu S, Liu W, Zhang H, Zhou
T, Wu D, Yang P, Shen L, Chen J and Jin Y: The promotion of bone
regeneration through positive regulation of angiogenicosteogenic
coupling using microRNA-26a. Biomaterials. 34:5048–5058. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Eskildsen T, Taipaleenmäki H, Stenvang J,
Abdallah BM, Ditzel N, Nossent AY, Bak M, Kauppinen S and Kassem M:
MicroRNA-138 regulates osteogenic differentiation of human stromal
(mesenchymal) stem cells in vivo. Proc Natl Acad Sci USA.
108:6139–6144. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li E, Zhang J, Yuan T and Ma B: MiR-143
suppresses osteogenic differentiation by targeting Osterix. Mol
Cell Biochem. 390:69–74. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang X, Guo B, Li Q, Peng J, Yang Z, Wang
A, Li D, Hou Z, Lv K, Kan G, et al: miR-214 targets ATF4 to inhibit
bone formation. Nat Med. 19:93–100. 2013. View Article : Google Scholar
|
|
34
|
De-Ugarte L, Yoskovitz G, Balcells S,
Güerri-Fernández R, Martinez-Diaz S, Mellibovsky L, Urreizti R,
Nogués X, Grinberg D, García-Giralt N and Díez-Pérez A: MiRNA
profiling of whole trabecular bone: Identification of
osteoporosis-related changes in MiRNAs in human hip bones. BMC Med
Genomics. 8:752015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jin HL, Kim JS, Kim YJ, Kim SJ, Broxmeyer
HE and Kim KS: Dynamic expression of specific miRNAs during
erythroid differentiation of human embryonic stem cells. Mol Cells.
34:177–183. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gu Y, Ma L, Song L, Li X, Chen D and Bai
X: miR-155 inhibits mouse osteoblast differentiation by suppressing
SMAD5 expression. Biomed Res Int. 2017:18935202017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Miyaki S, Sato T, Inoue A, Otsuki S, Ito
Y, Yokoyama S, Kato Y, Takemoto F, Nakasa T, Yamashita S, et al:
MicroRNA-140 plays dual roles in both cartilage development and
homeostasis. Genes Dev. 24:1173–1185. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Papaioannou G, Inloes JB, Nakamura Y,
Paltrinieri E and Kobayashi T: let-7 and miR-140 microRNAs
coordinately regulate skeletal development. Proc Natl Acad Sci USA.
110:E3291–E3300. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lin EA, Kong L, Bai XH, Luan Y and Liu CJ:
miR-199a, a bone morphogenic protein 2-responsive MicroRNA,
regulates chondrogenesis via direct targeting to Smad1. J Biol
Chem. 284:11326–11335. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gu YL, Rong XX, Wen LT, Zhu GX and Qian
MQ: miR-195 inhibits the proliferation and migration of
chondrocytes by targeting GIT1. Mol Med Rep. 15:194–200. 2017.
View Article : Google Scholar
|
|
41
|
Bai R, Zhao AQ, Zhao ZQ, Liu WL and Jian
DM: MicroRNA-195 induced apoptosis in hypoxic chondrocytes by
targeting hypoxia-inducible factor 1 alpha. Eur Rev Med Pharmacol
Sci. 19:545–551. 2015.PubMed/NCBI
|
|
42
|
Seidl CI, Martinez-Sanchez A and Murphy
CL: Derepression of MicroRNA-138 contributes to loss of the human
articular chondrocyte phenotype. Arthritis Rheumatol. 68:398–409.
2016. View Article : Google Scholar
|
|
43
|
Yan S, Wang M, Zhao J, Zhang H, Zhou C,
Jin L, Zhang Y, Qiu X, Ma B and Fan Q: MicroRNA-34a affects
chondrocyte apoptosis and proliferation by targeting the SIRT1/p53
signaling pathway during the pathogenesis of osteoarthritis. Int J
Mol Med. 38:201–209. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lian JB, Stein GS, van Wijnen AJ, Stein
JL, Hassan MQ, Gaur T and Zhang Y: MicroRNA control of bone
formation and homeostasis. Nat Rev Endocrinol. 8:212–227. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Cheng P, Chen C, He HB, Hu R, Zhou HD, Xie
H, Zhu W, Dai RC, Wu XP, Liao EY and Luo XH: miR-148a regulates
osteoclastogenesis by targeting V-maf musculoaponeurotic
fibrosarcoma oncogene homolog B. J Bone Miner Res. 28:1180–1190.
2013. View Article : Google Scholar
|
|
46
|
Mizoguchi F, Murakami Y, Saito T, Miyasaka
N and Kohsaka H: miR-31 controls osteoclast formation and bone
resorption by targeting RhoA. Arthritis Res Ther. 15:R1022013.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Sugatani T, Vacher J and Hruska KA: A
microRNA expression signature of osteoclastogenesis. Blood.
117:3648–3657. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chen C, Cheng P, Xie H, Zhou HD, Wu XP,
Liao EY and Luo XH: MiR-503 regulates osteoclastogenesis via
targeting RANK. J Bone Miner Res. 29:338–347. 2014. View Article : Google Scholar
|
|
49
|
Qu B, Xia X, Yan M, Gong K, Deng S, Huang
G, Ma Z and Pan X: miR-218 is involved in the negative regulation
of osteoclastogenesis and bone resorption by partial suppression of
p38MAPK-c-Fos-NFATc1 signaling: Potential role for osteopenic
diseases. Exp Cell Res. 338:89–96. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Guo LJ, Liao L, Yang L, Li Y and Jiang TJ:
MiR-125a TNF receptor-associated factor 6 to inhibit
osteoclastogenesis. Exp Cell Res. 321:142–152. 2014. View Article : Google Scholar
|
|
51
|
Laxman N, Rubin CJ, Mallmin H, Nilsson O,
Pastinen T, Grundberg E and Kindmark A: Global miRNA expression and
correlation with mRNA levels in primary human bone cells. RNA.
21:1433–1443. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Kaneto CM, Lima PS, Zanette DL, Prata KL,
Pina Neto JM, de Paula FJ and Silva WA Jr: COL1A1 and miR-29b show
lower expression levels during osteoblast differentiation of bone
marrow stromal cells from Osteogenesis Imperfecta patients. BMC Med
Genet. 15:1471–2350. 2014. View Article : Google Scholar
|
|
53
|
Ou M, Zhang X, Dai Y, Gao J, Zhu M, Yang
X, Li Y, Yang T and Ding M: Identification of potential
microRNA-target pairs associated with osteopetrosis by deep
sequencing, iTRAQ proteomics and bioinformatics. Eur J Hum Genet.
22:625–632. 2014. View Article : Google Scholar
|
|
54
|
Franceschetti T, Kessler CB, Lee SK and
Delany AM: miR-29 promotes murine osteoclastogenesis by regulating
osteoclast commitment and migration. J Biol Chem. 288:33347–33360.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Xu S, Cecilia Santini G, De Veirman K,
Vande Broek I, Leleu X, De Becker A, Van Camp B, Vanderkerken K and
Van Riet I: Upregulation of miR-135b is involved in the impaired
osteogenic differentiation of mesenchymal stem cells derived from
multiple myeloma patients. PLoS One. 8:e797522013. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Ell B and Kang Y: MicroRNAs as regulators
of bone homeostasis and bone metastasis. Bonekey Rep. 3:5492014.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zoni E and van der Pluijm G: The role of
microRNAs in bone metastasis. J Bone Oncol. 5:104–108. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Li H, Zhang K, Liu LH, Ouyang Y, Guo HB,
Zhang H, Bu J and Xiao T: MicroRNA screening identifies circulating
microRNAs as potential biomarkers for osteosarcoma. Oncol Lett.
10:1662–1668. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Lian F, Cui Y, Zhou C, Gao K and Wu L:
Identification of a plasma four-microRNA panel as potential
noninvasive biomarker for osteosarcoma. PLoS One. 10:e01214992015.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Dong J, Liu Y, Liao W, Liu R, Shi P and
Wang L: miRNA-223 is a potential diagnostic and prognostic marker
for osteosarcoma. J Bone Oncol. 5:74–79. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Ma W, Zhang X, Chai J, Chen P, Ren P and
Gong M: Circulating miR-148a is a significant diagnostic and
prognostic biomarker for patients with osteosarcoma. Tumour Biol.
35:12467–12472. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Ziyan W, Shuhua Y, Xiufang W and Xiaoyun
L: MicroRNA-21 is involved in osteosarcoma cell invasion and
migration. Med Oncol. 28:1469–1474. 2011. View Article : Google Scholar
|
|
63
|
Ren X, Shen Y, Zheng S, Liu J and Jiang X:
miR-21 predicts poor prognosis in patients with osteosarcoma. Br J
Biomed Sci. 73:158–162. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Nakka M, Allen-Rhoades W, Li Y, Kelly AJ,
Shen J, Taylor AM, Barkauskas DA, Yustein JT, Andrulis IL, Wunder
JS, et al: Biomarker significance of plasma and tumor miR-21,
miR-221, and miR-106a in osteosarcoma. Oncotarget. 27:96738–96752.
2017.
|
|
65
|
Keremu A, Aini A, Maimaitirexiati Y, Liang
Z, Aila P, Xierela P, Tusun A, Moming H and Yusufu A: Overcoming
cisplatin resistance in osteosarcoma through the miR-199a-modulated
inhibition of HIF-1α. Biosci Rep. BSR20170080. 2017. View Article : Google Scholar
|
|
66
|
Dalle Carbonare L, Valenti MT, Zanatta M,
Donatelli L and Lo Cascio V: Circulating mesenchymal stem cells
with abnormal osteogenic differentiation in patients with
osteoporosis. Arthritis Rheum. 60:3356–3365. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Weilner S, Skalicky S, Salzer B, Keider V,
Wagner M, Hildner F, Gabriel C, Dovjak P, Pietschmann P,
Grillari-Voglauer R, et al: Differentially circulating miRNAs after
recent osteoporotic fractures can influence osteogenic
differentiation. Bone. 79:43–51. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Kocijan R, Muschitz C, Geiger E, Skalicky
S, Baierl A, Dormann R, Plachel F, Feichtinger X, Heimel P,
Fahrleitner-Pammer A, et al: Circulating microRNA signatures in
patients with idiopathic and postmenopausal osteoporosis and
fragility fractures. J Clin Endocrinol Metab. 101:4125–4134. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Li H, Wang Z, Fu Q and Zhang J: Plasma
miRNA levels correlate with sensitivity to bone mineral density in
postmenopausal osteoporosis patients. Biomarkers. 19:553–556. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Seeliger C, Karpinski K, Haug AT, Vester
H, Schmitt A, Bauer JS and van Griensven M: Five freely circulating
miRNAs and bone tissue miRNAs are associated with osteoporotic
fractures. J Bone Miner Res. 29:1718–1728. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Hackl M, Heilmeier U, Weilner S and
Grillari J: Circulating microRNAs as novel biomarkers for bone
diseases-complex signatures for multifactorial diseases? Mol Cell
Endocrinol. 432:83–95. 2016. View Article : Google Scholar
|
|
72
|
Yavropoulou MP, Anastasilakis AD, Makras
P, Tsalikakis DG, Grammatiki M and Yovos JG: Expression of
microRNAs that regulate bone turnover in the serum of
postmenopausal women with low bone mass and vertebral fractures.
Eur J Endocrinol. 176:169–176. 2017. View Article : Google Scholar
|
|
73
|
Zhang X, Li Y, Chen YE, Chen J and Ma PX:
Cell-free 3D scaffold with two-stage delivery of miRNA-26a to
regenerate critical-sized bone defects. Nat Commun. 7:103762016.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Liu J, Dang L, Li D, Liang C, He X, Wu H,
Qian A, Yang Z, Au DW, Chiang MW, et al: A delivery system
specifically approaching bone resorption surfaces to facilitate
therapeutic modulation of microRNAs in osteoclasts. Biomaterials.
52:148–160. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Wright NC, Looker AC, Saag KG, Curtis JR,
Delzell ES, Randall S and Dawson-Hughes B: The recent prevalence of
osteoporosis and low bone mass in the United States based on bone
mineral density at the femoral neck or lumbar spine. J Bone Miner
Res. 29:2520–2526. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Zhang J, Tu Q, Bonewald LF, He X, Stein G,
Lian J and Chen J: Effects of miR-335-5p in modulating osteogenic
differentiation by specifically downregulating Wnt antagonist DKK1.
J Bone Miner Res. 26:1953–1963. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Sugatani T and Hruska KA: Impaired
micro-RNA pathways diminish osteoclast differentiation and
function. J Biol Chem. 284:4667–4678. 2009. View Article : Google Scholar :
|
